Country antimalarial drug policies: by region
- WHO African Region
- WHO Region of the Americas
- WHO South-East Asia Region
- WHO European Region
- WHO Eastern Mediterranean Region
WHO Western Pacific Region
| Global AMDP database - WHO Western Pacific Region | ||||||||
| Last Updated: February 2011 | P. falciparum | P.vivax | ||||||
| COUNTRY/ AREA | SPECIES | uncomplicated | treatment failure | severe malaria | pregnancy | treatment | ||
| un- confirmed | lab- confirmed | treatment | prevention | |||||
| Cambodia | fal; vivax | AS+MQ, (DHA+PPQ + PQ)* | QN(7d) +T(7d) | AS+DHA+PPQ | QN or AS+MQ | DHA-PPQ+PQ | ||
| China, Yunnan, Hainan | fal; vivax | DHA+PPQ; AS+AQ; ART+NQ;ART+PPQ | AM; PYR; AS | Q(7d) / CQ | CQ+PQ(8d) | |||
| China, Other | vivax only | CQ+PQ(5d) | ||||||
| Lao PDR | fal; vivax | AL | QN+D | AS+AL | QN (2nd and 3rd trimester -AL) | CQ+PQ(14d) | ||
| Malaysia | fal; vivax | AS+MQ | QN+T | QN+T | CQ | CQ+PQ(14d) | ||
| Papua New Guinea | fal; vivax | AL | DHA-PPQ | AS; AM | QN/AL | CQ weekly | CQ+PQ(14d) | |
| Phillippines | fal; vivax | AL+PQ | QN+T | QN+T | QN | CQ(wkly)/SP(IPT) | CQ+PQ(14d) | |
| Republic of Korea | vivax only | CQ+PQ(14d) | ||||||
| Solomon Islands | fal; vivax | AL | QN(7d) | AS+AL | AL | CQ | AL+PQ(14d) | |
| Vanuatu | fal; vivax | AL | QN(7d) | QN(7d) | CQ+SP | CQ weekly | AL+PQ(14d) | |
| Viet Nam | fal; vivax | DHA+PPQ | AS+MQ or QN7 | AS inj/ QN inj | Q(7d) /AS in 2&3 trimesters | CQ weekly | CQ+PQ(14d) | |
AL=Artemether-lumefantrine
AM=Artemether
AS=Artesunate
CL=Clindamycin
CQ=Chloroquine
DHA+PPQ=Dihydroartemisinin- Piperaquine
IPT=Intermittent Preventive Treatment
MQ= Mefloquine
PQ=Primaquine
PYR=Pyronaridine
QN=Quinine
SP=Sulphadoxine-pyrimethamine
T=Tetracycline